MRI-guided, open trial of abciximab for ischemic stroke within a 3- to 24-hour window.
Mitsias, P D
MRI-guided, open trial of abciximab for ischemic stroke within a 3- to 24-hour window. [electronic resource] - Neurology Aug 2005 - 612-5 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
1526-632X
10.1212/01.wnl.0000172862.33641.92 doi
Abciximab
Aged
Aged, 80 and over
Antibodies, Monoclonal--administration & dosage
Anticoagulants--administration & dosage
Brain--drug effects
Brain Ischemia--diagnosis
Cerebral Arteries--drug effects
Female
Humans
Immunoglobulin Fab Fragments--administration & dosage
Infusions, Intravenous
Intracranial Hemorrhages--chemically induced
Magnetic Resonance Imaging
Male
Middle Aged
Patient Selection
Stroke--diagnosis
Time Factors
Treatment Outcome
MRI-guided, open trial of abciximab for ischemic stroke within a 3- to 24-hour window. [electronic resource] - Neurology Aug 2005 - 612-5 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
1526-632X
10.1212/01.wnl.0000172862.33641.92 doi
Abciximab
Aged
Aged, 80 and over
Antibodies, Monoclonal--administration & dosage
Anticoagulants--administration & dosage
Brain--drug effects
Brain Ischemia--diagnosis
Cerebral Arteries--drug effects
Female
Humans
Immunoglobulin Fab Fragments--administration & dosage
Infusions, Intravenous
Intracranial Hemorrhages--chemically induced
Magnetic Resonance Imaging
Male
Middle Aged
Patient Selection
Stroke--diagnosis
Time Factors
Treatment Outcome